Patents by Inventor Mark Penfold

Mark Penfold has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antibodies that bind CXCR7 epitopes
    Patent number: 8088895
    Abstract: Antibodies that bind CXCR7 epitopes, as well as methods of identifying CXCR7 modulators are described.
    Type: Grant
    Filed: October 10, 2007
    Date of Patent: January 3, 2012
    Assignee: ChemoCentryx, Inc.
    Inventors: Brett Premack, Zhenhua Miao, Mark Penfold
  • ANTIBODIES THAT BIND CXCR7 EPITOPES
    Publication number: 20090022717
    Abstract: Antibodies that bind CXCR7 epitopes, as well as methods of identifying CXCR7 modulators are described.
    Type: Application
    Filed: October 10, 2007
    Publication date: January 22, 2009
    Applicant: ChemoCentryx, Inc.
    Inventors: Brett Premack, Zhenhua Miao, Mark Penfold
  • Bicyclic compounds as inhibitors of chemokine binding to US28
    Patent number: 7101894
    Abstract: Methods for treating CMV or a CMV-related disease are provided that use compounds having the formula: wherein Ar is a substituted or unsubstituted 5–14 membered heteroaryl group having from 1 to 5 heteroatoms as ring members; R1 is selected from the group consisting of substituted or unsubstituted aryl(C1–C4)alkyl, heteroaryl(C1–C4)alkyl, —C(O)R11, and —C(O)NR11R12, wherein each R11 and R12 independently is substituted or unsubstituted aryl, substituted or unsubstituted aryl(C1–C4)alkyl, substituted or unsubstituted (C4–C8)cycloalkyl(C1–C4)alkyl, substituted or unsubstituted heteroaryl, substituted or unsubstituted heteroaryl(C1–C4)alkyl and substituted or unsubstituted hetero(C4–C8)cycloalkyl(C1–C4)alkyl; R2 is H or (C1–C8)alkyl; and ZN is a substituted or unsubstituted hetero(C6–C10)bicycloalkyl group.
    Type: Grant
    Filed: August 29, 2002
    Date of Patent: September 5, 2006
    Assignee: ChemoCentryx, Inc.
    Inventors: Brian E. McMaster, Thomas J. Schall, Mark Penfold, J. J. Wright, Daniel J. Dairaghi
  • Method of preventing transport of a neurotropic virus and identifying agents for achieving same
    Patent number: 6953661
    Abstract: A method of preventing transport of a Herpes simplex virus within a neuron, comprising preventing interaction between a structural tegument protein US11 of the virus and a motor protein, Kinesin in the neuron such that virus transport in the neuron is prevented. An antiviral composition is also provided, comprising a compound capable of preventing interaction between a structural tegument protein of a neurotropic virus and a neuron or cell.
    Type: Grant
    Filed: July 20, 2000
    Date of Patent: October 11, 2005
    Assignees: Westmead Hospital, The University of Sydney
    Inventors: Russell John Diefenbach, Monica Miranda-Saksena, Eve Margaret Diefenbach, David James Holland, Anthony Lawrence Cunningham, Mark Penfold, Patricia Joan Armati
  • Immunologic activities of rhesus cytomegalovirus encoded IL-10 and human cytomegalovirus encoded IL-10
    Publication number: 20050191274
    Abstract: The present invention is provides pharmaceutical compositions and prophylactic and therapeutic methods of treatment for immune disorders using rhesus or human CMV IL-10. The invention is useful for inhibiting lymphocyte proliferation and underlying cellular events both in vitro and in vivo.
    Type: Application
    Filed: February 10, 2005
    Publication date: September 1, 2005
    Applicant: ChemoCentryx, Inc.
    Inventors: Thomas Schall, Mark Penfold, Juliet Spencer
  • Arylamines as inhibitors of chemokine binding to US28
    Patent number: 6821998
    Abstract: Methods for treating CMV and CMV-related diseases are provided that use compounds having the formula: wherein the subscripts m and n are each independently integers from 1 to 2; and the R groups are as defined in the specification.
    Type: Grant
    Filed: August 29, 2002
    Date of Patent: November 23, 2004
    Assignee: ChemoCentryx, Inc.
    Inventors: Brian E. McMaster, Thomas J. Schall, Mark Penfold, J. J. Wright, Daniel J. Dairaghi
  • Bicyclic compounds as inhibitors of chemokine binding to US28
    Publication number: 20030149055
    Abstract: Methods for treating CMV or a CMV-related disease are provided that use compounds having the formula: 1
    Type: Application
    Filed: August 29, 2002
    Publication date: August 7, 2003
    Applicant: ChemoCentryx
    Inventors: Brian E. McMaster, Thomas J. Schall, Mark Penfold, J. J. Wright, Daniel J. Dairaghi
  • Arylamines as inhibitors of chemokine binding to US28
    Publication number: 20030114423
    Abstract: Methods for treating CMV and CMV-related diseases are provided that use compounds having the formula: 1
    Type: Application
    Filed: August 29, 2002
    Publication date: June 19, 2003
    Applicant: ChemoCentryx, Inc.
    Inventors: Brian E. McMaster, Thomas J. Schall, Mark Penfold, J.J. Wright, Daniel J. Dairaghi
  • Immunologic activities of rhesus cytomegalovirus encoded IL-10 and human cytomegalovirus encoded IL-10
    Publication number: 20020197234
    Abstract: The present invention is provides pharmaceutical compositions and prophylactic and therapeutic methods of treatment for immune disorders using rhesus or human CMV IL-10. The invention is useful for inhibiting lymphocyte proliferation and underlying cellular events both in vitro and in vivo.
    Type: Application
    Filed: July 30, 2001
    Publication date: December 26, 2002
    Applicant: ChemoCentryx, Inc.
    Inventors: Thomas J. Schall, Mark Penfold, Juliet Spencer